Morning Buzz: Flexion Therapeutics (FLXN), Apple (AAPL), Priceline (PCLN), Catalyst Pharmaceuticals (CPRX)

Shares of Flexion Therapeutics, Inc. (FLXN) are higher by 31% to $14.28 in pre-market trading on Wednesday after the pharmaceutical company said its lead drug candidate Zilretta met the main goal of reducing pain in patients with moderate to severe osteoarthritis knee pain in a Phase 3 study. — Apple Inc. (AAPL) – CEO Tim […] View the full post at: Morning Buzz: Flexion Therapeutics (FLXN), Apple (AAPL), Priceline (PCLN), Catalyst Pharmaceuticals (CPRX) Related posts: Apple’s (AAPL) Short Interest Nosedives Apple’s iPad Launched in Stores After Intense Buzz Summer Travel Deals Boost Priceline Q2 Earnings